OHSU emphasizes crucial role of vaccines, including hepatitis B, for babies
December 11, 2025
Amid changes in federal recommendations, pediatric health experts remind community members of the safety, efficacy of routine childhood vaccines.
Study implicates enzyme in neurodegenerative conditions
December 11, 2025
OHSU research finds a specific enzyme is involved in myelin breakdown that causes conditions such as MS, stroke, Alzheimer’s.
Estudio de OHSU: La terapia CAR-T muestra supervivencia a largo plazo para pacientes con linfoma
December 11, 2025
Los datos de cinco años de un ensayo clínico para adultos con linfoma de células B grandes recidivante o refractario confirman remisiones duraderas en pacientes de alto riesgo.
OHSU study: CAR-T therapy shows long-term survival for patients with lymphoma
December 11, 2025
Five-year data from clinical trial for adults with relapsed or refractory large B-cell lymphoma confirms lasting remissions in high-risk patients.
OHSU selects health system chief executive officer, executive vice president
November 24, 2025
Announcement from Shereef Elnahal, M.D., M.B.A.
OHSU part of U.K.-based initiative to transform modeling of human disease
November 20, 2025
OHSU scientist collaborating to improve understanding of blood vessel function.
OHSU es parte de iniciativa basada en el Reino Unido para transformar el modelado de enfermedades humanas
November 20, 2025
Científico de OHSU colabora para mejorar la comprensión de la función de vasos sanguíneos.
Joint OHSU and Adventist Health Portland statement
November 13, 2025
OHSU and Adventist Health Portland update clinical affiliation.
Investigadores/as de OHSU desarrollan prometedor fármaco para cáncer de mama agresivo
November 07, 2025
También podría ser útil algún día para tratar otros cánceres afectados por la misma enzima, tales como el glioma, el cáncer de páncreas, el carcinoma tiroideo.